Tris Pharma receives USFDA approval for ONYDA XR, a liquid non-stimulant ADHD medication

Read more

Merck KGaA announces its largest investment in Asia

Read more

FDA grants priority review to Genentech’s Inavolisib

Read more

Glenmark creates mass awareness around Hypertension

Read more

Entod Pharma launches Vitamin D3 eye drops

Read more

AbbVie’s immunology portfolio to offset Humira losses: GlobalData

Read more

USFDA grants approval of Bkemv to Amgen

Read more

Total prevalent cases of osteoporosis to cross 58.05 mn in 7MM by 2033: GlobalData

Read more

Special Address: Ms Archana Jatkar, Associate Secretary General, IPA

Read more

Special Address: Anil Matai, Director General, OPPI

Read more